488
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

A Transient Improvement in Renal Function Occurs after Ischemic Stroke

, , , , , & show all
Pages 7-12 | Received 29 Apr 2011, Accepted 11 Sep 2011, Published online: 25 Oct 2011

REFERENCES

  • Cuadra AE, Shan Z, Sumners C, Raizada MK. A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? Pharmacol Ther. 2010;125:27–38.
  • DiBona GF. The sympathetic nervous system and hypertension: Recent developments. Hypertension. 2004;43:147–150.
  • DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75–197.
  • Wyss JM, Oparil S, Sripairojthikoon W. Neuronal control of the kidney: Contribution to hypertension. Can J Physiol Pharmacol. 1992;70:759–770.
  • O’Hagan KP, Thomas GD, Zambraski EJ. Renal denervation decreases blood pressure in DOCA-treated miniature swine with established hypertension. Am J Hypertens. 1990;3:62–64.
  • Alexander BT, Hendon AE, Ferril G, Dwyer TM. Renal denervation abolishes hypertension in low-birth-weight offspring from pregnant rats with reduced uterine perfusion. Hypertension. 2005;45:754–758.
  • Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension. 1995;25:893–897.
  • Sykora M, Diedler J, Turcani P, Hacke W, Steiner T. Baroreflex: A new therapeutic target in human stroke? Stroke. 2009;40:e678–e682.
  • Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol. 2010;9:105–118.
  • Tikhonoff V, Zhang H, Richart T, Staessen JA. Blood pressure as a prognostic factor after acute stroke. Lancet Neurol. 2009;8:938–948.
  • Harrigan M. Cerebral salt wasting syndrome: A review. Neurosurgery. 1996;38:152–160.
  • Amer M, Haase J, Bie P, Holmegaard SN, Djurberg H. Cerebral salt wasting syndrome and syndrome of inappropriate antidiuretic hormone secretion in subarachnoid hemorrhage caused by ruptured berry aneurysms. Pan Arab J Neurosurg. 2000;4:25–31.
  • Lang W, Lalouschek W, for the Vienna Stroke Study Group. The Vienna Stroke Registry—Objectives and methodology. Wien Klin Wochenschr. 2001;113:141–147.
  • Lalouschek W, Lang W, Muellner M. Current strategies of secondary prevention after a cerebrovascular event: The Vienna Stroke Registry. Stroke. 2001;32:2860–2866.
  • Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: An occult burden. Adv Chronic Kidney Dis. 2008;15:123–132.
  • Seliger SL, Longstreth Jr, WT. Lessons about brain vascular disease from another pulsating organ, the kidney. Stroke. 2008;39:5–6.
  • Khatri M, Wright CB, Nickolas TL, . Chronic kidney disease is associated with white matter hyperintensity volume. The Northern Manhattan Study (NOMAS). Stroke. 2007;38:3121–3126.
  • Yang XL, So WY, Kong AP, . Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: The Hong Kong Diabetes Registry. Diabetes Care. 2007;30:65–70.
  • Isomaa B, Almgren P, Tuomi T, . Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689.
  • Yang X, So WY, Tong PC, . Development and validation of an all-cause mortality risk score in type 2 diabetes: The Hong Kong Diabetes Registry. Arch Intern Med. 2008;168:451–457.
  • Krumholz HM, Chen YT, Vaccarino V, . Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. Am J Cardiol. 2000;85:1110–1113.
  • Forman DE, Butler J, Wang Y, . Incidence, predictors at admission and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61–67.
  • Mielniczuk LM, Pfeffer MA, Lewis EF, . Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. Clin J Am Soc Nephrol. 2009;4:1811–1817.
  • Melin J, Hellberg O, Fellström B. Hyperglycaemia and renal ischemia-reperfusion injury. Nephrol Dial Transplant. 2003;18:460–462.
  • Rizvi AA. Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: Emerging concepts. Am J Med Sci. 2009;338:310–318.
  • von Haehling S, Schefold JC, Lainscak M, Doehner W, Anker SD. Inflammatory biomarkers in heart failure revisited: Much more than innocent bystanders. Heart Fail Clin. 2009;5:549–560.
  • Iadecola C, Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol. 2001;14:89–94.
  • Liu M, Dziennis S, Hurn PD, Alkayed NJ. Mechanisms of gender-linked ischemic brain injury. Restor Neurol Neurosci. 2009;27:163–179.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.